Cosmos Health (NASDAQ:COSM – Get Free Report) and electroCore (NASDAQ:ECOR – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, analyst recommendations, valuation, institutional ownership and profitability.
Analyst Recommendations
This is a breakdown of recent recommendations and price targets for Cosmos Health and electroCore, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Cosmos Health | 1 | 0 | 0 | 0 | 1.00 |
| electroCore | 1 | 1 | 1 | 0 | 2.00 |
electroCore has a consensus target price of $18.00, indicating a potential upside of 150.35%. Given electroCore’s stronger consensus rating and higher probable upside, analysts plainly believe electroCore is more favorable than Cosmos Health.
Earnings & Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Cosmos Health | $65.27 million | 0.18 | -$19.15 million | ($0.64) | -0.29 |
| electroCore | $32.03 million | 1.86 | -$13.97 million | ($1.77) | -4.06 |
electroCore has lower revenue, but higher earnings than Cosmos Health. electroCore is trading at a lower price-to-earnings ratio than Cosmos Health, indicating that it is currently the more affordable of the two stocks.
Volatility & Risk
Cosmos Health has a beta of 4.79, indicating that its stock price is 379% more volatile than the S&P 500. Comparatively, electroCore has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500.
Institutional and Insider Ownership
12.6% of Cosmos Health shares are held by institutional investors. Comparatively, 26.7% of electroCore shares are held by institutional investors. 26.2% of Cosmos Health shares are held by insiders. Comparatively, 13.8% of electroCore shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Profitability
This table compares Cosmos Health and electroCore’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Cosmos Health | -30.41% | -52.85% | -17.87% |
| electroCore | -44.08% | -1,956.38% | -83.30% |
Summary
Cosmos Health beats electroCore on 8 of the 14 factors compared between the two stocks.
About Cosmos Health
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors. It sells its products through independent wholesale distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
About electroCore
electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.
